期刊文献+

眼睑套细胞淋巴瘤临床病理分析 被引量:5

Clinical pathology analysis on primary eyelid mantle cell lymphoma
下载PDF
导出
摘要 目的探讨眼睑原发性套细胞淋巴瘤(mantlecelllymphoma,MCL)的临床病理学特点及免疫表型。方法应用影像学及组织病理学技术对1例眼睑原发性MCL进行研究,观察其影像学特征、病理组织学形态及免疫组化表型。结果MRI提示右眼眶下缘片状等T1等T2信号影,边界清楚,大小约2.4cm×0.9cm×0.6cm,增强扫描轻度均匀强化,肿物邻近眼球,眼外肌结构完整,未见明确骨质破坏;光镜示肿瘤细胞弥漫性增生,肿瘤细胞小至中等大,核型不规则,染色质中度稀疏,可见核分裂像;肿瘤组织中散在分布上皮样组织细胞以及玻璃样变性红染的血管壁。免疫组化示:CD20(+),CD3(-),CD5(+),CyclinD1(+)。结论原发于眼睑部位的MCL非常罕见,影像学无特征性的表现,组织学形态表现独特,免疫组化标记有助于该病的诊断。 Objective To investigate the pathological characteristics and immune phenotypes of primary eyelid mantle cell lymphoma (MCL). Methods Imaging and histopathology techniques were used to observe radiologieal features, pathological histology and immunohistochemical phenotype of primary eyelid MCL. Results MRI hinted the same T1 and T2 signal with clear boundaries and a light uniform enhancement by means of enhanced scan in right orbit. The volume of the tumor was about 2.4 cm × 0.9 cm× 0.6 cm. The tumor close to the eyeball and the extraocular muscle and bone structure was integrity. The diffuse proliferative tumor cells were small to medium large with irregular karyotype and sparse chromatin. Hyaline degenerated and red dyed vascular wall and epithelioid cells distributed in the tumor. The tumor cells were positively expressed CD20, CD3, CD5 and CyclinD1 protein. Conclusion Primary eyelid MCL is rare, which has a unique histological performance. Immunohistochemical markers can help the diagnosis of the disease.
作者 华兴 于莉娜
出处 《国际医药卫生导报》 2013年第18期2791-2794,共4页 International Medicine and Health Guidance News
基金 基金项目:国家自然科学基金青年科学基金项目(81001111),广东省自然科学基金资助项目(S2011040003696)
关键词 眼睑 套细胞淋巴瘤 免疫表型 Eyelid Mantle cell lymphoma (MCL) Immune phenotype
  • 相关文献

参考文献11

  • 1苏基滢,常春康.套细胞淋巴瘤[J].癌症进展,2011,9(4):414-419. 被引量:7
  • 2游启生,李彬,周小鸽,孙宪丽,安裕志,史季桐,李辽青,高飞.112例眼附属器淋巴增生性病变临床组织病理学初步分析[J].中华眼科杂志,2005,41(10):871-876. 被引量:38
  • 3Zhil'tsova MG, Kaplina AV. Diagnostic possibilities of fine-needle aspiration biopsy in malignant tumors of the orbit[J]. Vestn Oftalmol, 2001,117(3):31-34.
  • 4Knowles DM, Jakobiec FA. Malignant lymphomas and lymphoid hyperplasias that occur in the ocular adnexa (orbit, conjunctiva, and eyelids ) .In: Knowles DM, ed. Neoplastic hematopathology. Baltimore: Williams & Wilkines, 1992, 1009-1046.
  • 5常莉,宋国祥.眼眶淋巴增生病的免疫学分类及其临床意义[J].国外医学(眼科学分册),1991,15(2):106-109. 被引量:4
  • 6Mauriello JA Jr, Piacentini M, Pokorny KS, et al. The role of proliferating cell nuclear antigen (PCNA) in differentiating idiopathic orbital inflammatory disease and lymphoid proliferations[J]. Ophthal Ptast Reconstr Surg, 1997,13(1):26-30.
  • 7Alexandra S, Izidore SL. Extranodal marginal zone lymphoma of the ocular adnexal[J]. Blood,2009,114(3):501-510.
  • 8黄杜茹,黄中宁,庄恒国.眼睑肿物为首发的MCL-例[J].中华实用眼科杂志,2008,26(4):415-416.
  • 9官兵,周晓军.淋巴瘤病理诊断常用免疫组化抗体的选择策略[J].临床与实验病理学杂志,2011,27(1):1-9. 被引量:15
  • 10Ant o nia OH, Silvia FM, Priam V, et al. Molecular biology of mantle cell lymphoma:From profiling studies to new therapeutic strategies[J]. Blood Reviews, 2009,23(5):205-216.

二级参考文献59

  • 1徐青,肖利华,何彦津,李敏,李宁,高子芬.眼附属器黏膜相关淋巴组织型淋巴瘤和反应性淋巴组织增生的鉴别诊断研究[J].中华眼科杂志,2004,40(12):795-799. 被引量:12
  • 2王立,夏瑞南,李甘地.原发性眼附属器恶性淋巴瘤38例的免疫组织化学研究[J].华西医科大学学报,1995,26(2):224-226. 被引量:3
  • 3黄灵芝.硼替佐米有望成为治疗非霍奇金淋巴瘤新药[J].国外医学(药学分册),2006,33(5):382-383. 被引量:2
  • 4Taylor C R.IHC and the WHO classification of lymphomas:cost effective immunohistochemistry using a deductive reasoning "decision tree" approach[J].Appl Immunohistochem Mol Morphol,2009,17:366-74.
  • 5Fabian P,Boudova L.Comments on the 4th WHO classification of lymphomas[J].Klin Onkol,2009,22:121-2.
  • 6Loddenkemper C,Anagnostopoulos I,Hummel M,et al.Differential Emu enhancer activity and expression of BOB.1/OBF.1,Oct2,PU.1,and immunoglobulin in reactive B-cell populations,B-cell non-Hodgkin lymphomas,and Hodgkin lymphomas[J].J Pathol,2004,202:60-9.
  • 7Adams H,Liebisch P,Schmid P,et al.Diagnostic utility of the B-cell lineage markers CD20,CD79α,PAX5,and CD19 in paraffin-embedded tissues from lymphoid neoplasms[J].Appl Immunohistochem Mol Morphol,2009,17:96-101.
  • 8Higgins R A,Blankenship J E,Kinney M C.Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma[J].Arch Pathol Lab Med,2008,132:441-61.
  • 9Sotomayor E A,Shah I M,Sanger W G,et al.In situ follicular lymphoma with a 14;18 translocation diagnosed by a multimodal approach[J].Exp Mol Pathol,2007,83:254-8.
  • 10Sjo L D,Poulsen C B,Hansen M,et al.Profiling of diffuse large B-cell lymphoma by immunohistochemistry:identification of prognostic subgroups[J].Eur J Haematol,2007,79:501-7.

共引文献60

同被引文献64

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部